Efficacy of sacubitril‐valsartan and SGLT2 inhibitors in heart failure with reduced ejection fraction: A systematic review and meta‐analysis

BACKGROUND: Sacubitril‐valsartan (SV) monotherapy has been shown to help patients with Heart failure with reduced ejection fraction (HFrEF), but whether adding a sodium‐glucose cotransporter‐2 inhibitor (SGLT2i) improves treatment results even more is unknown. HYPOTHESIS: The goal of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Mo, Xingchun, Lu, Ping, Yang, Xiaojing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577570/
https://www.ncbi.nlm.nih.gov/pubmed/37465885
http://dx.doi.org/10.1002/clc.24085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577570/
https://www.ncbi.nlm.nih.gov/pubmed/37465885
http://dx.doi.org/10.1002/clc.24085

Ejemplares similares